Industry News - BioPharm International

ADVERTISEMENT

Industry News
The latest news about industry suppliers, business activities, people.

AstraZeneca and MRC Laboratory of Molecular Biology Launch Joint Research Fund

May 15, 2014

AstraZeneca will collaborate with the Medical Research Council Laboratory of Molecular Biology to fund a range of pre-clinical research projects.

KBI Biopharma Acquires Merck's Biologics Operations

May 13, 2014

KBI Biopharma acquires Merck's microbial process development and manufacturing operations in Colorado.

Eurofins to Acquire ViraCor-IBT Laboratories

May 13, 2014

Eurofins Scientific will acquire ViraCor-IBT Laboratories for $255 million.

Shire Acquires Lumena Pharmaceuticals

May 12, 2014

Shire expands rare disease portfolio with acquisition of Lumena Pharmaceuticals.

NIH Study Reveals New Cancer Immunotherapy Method

May 9, 2014

Scientists at the National Cancer Institute found a new cancer immunotherapy method that could be effective against a wide range of cancers.

Cumberland Pharmaceuticals and Gloria Pharmaceuticals Announce R&D Investment

May 9, 2014

Cumberland Pharmaceuticals and Gloria Pharmaceuticals invest $1 million each in Cumberland Emerging Technologies.

Boehringer Ingelheim and Connexios Life Sciences Enter Agreement for AMPK Activators

May 9, 2014

Boehringer Ingelheim and Connexios Life Sciences announce global research collaboration agreement for AMPK agonists.

Gallus BioPharmaceuticals Enters Agreement with Omni Bio Pharmaceutical

May 1, 2014

Gallus BioPharmaceuticals enters a cell line optimization and manufacturing agreement with Omni Bio Pharmaceutical.

Gallus BioPharmaceuticals Uses ambr15 Micro Bioreactor to Develop Novel Antibodies and Biosimilars

April 30, 2014

TAP Biosystems announced that Gallus BioPharmaceuticals is using its ambr15 micro bioreactor system to optimize process development and clone selection of novel antibody therapeutics and biosimilars.

ADVERTISEMENT

ADVERTISEMENT

Click here